China, Aug. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Feasibility Study on Therapeutic Strategies for Pancreatic Acinar Cell Carcinoma Guided by Staging and Molecular Characteristics'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130583
Registration Time: 2026/08/21
Type: Interventional study
Primary Sponsor: Peking Union Medical College Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=329027
Published by HT Digital Content Services with permission from Health Daily Digest....